Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 3.86 is 1113% above its 5-year average of 0.32, near the high end of its 5-year range (-1.60–5.60).
As of the fiscal period ended Wednesday, December 31, 2025. 15.74% above its 12-month average of 3.33.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 30 quarters.
Reported annual fiscal-period values; no daily interpolation.
EARNINGS PER SHARE (EPS)
3.86
EARNINGS PER SHARE (EPS) AVG TTM
3.33
EARNINGS PER SHARE (EPS) AVG 3Y
1.17
EARNINGS PER SHARE (EPS) AVG 5Y
0.32
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+15.74%
CURRENT VS 3Y AVG
+230.62%
CURRENT VS 5Y AVG
+1112.57%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
TransMedics Group, Inc.
Market Cap
$2.64B
Earnings Per Share (EPS)
3.86
TTM Avg
3.33
3Y Avg
1.17
5Y Avg
0.32
Market Cap
$2.76B
Earnings Per Share (EPS)
-3.15
TTM Avg
-3.74
3Y Avg
-3.13
5Y Avg
-1.84
Market Cap
$1.26B
Earnings Per Share (EPS)
-0.99
TTM Avg
-3.50
3Y Avg
-23.24
5Y Avg
-16.84
Market Cap
$468.68M
Earnings Per Share (EPS)
-2.17
TTM Avg
-1.36
3Y Avg
-1.12
5Y Avg
-1.12
Market Cap
$15.31M
Earnings Per Share (EPS)
-9.05
TTM Avg
-19.23
3Y Avg
-15.56
5Y Avg
-14.25
Market Cap
$7.06B
Earnings Per Share (EPS)
-0.09
TTM Avg
0.57
3Y Avg
0.18
5Y Avg
-0.06
Market Cap
$7.81B
Earnings Per Share (EPS)
-0.54
TTM Avg
-0.79
3Y Avg
-1.41
5Y Avg
-1.76
Market Cap
$8.18B
Earnings Per Share (EPS)
-1.44
TTM Avg
-3.00
3Y Avg
-2.43
5Y Avg
-2.16
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TransMedics Group, Inc. (TMDX) | $2.64B | 3.86 | 3.33 | 1.17 | 0.32 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.76B | -3.15 | -3.74 | -3.13 | -1.84 |
| Teladoc Health, Inc. (TDOC)vs › | $1.26B | -0.99 | -3.50 | -23.24 | -16.84 |
| Shoulder Innovations, Inc. (SI)vs › | $468.68M | -2.17 | -1.36 | -1.12 | -1.12 |
| NRC Health (NRC)vs › | $440.37M | 0.25 | 0.79 | 1.03 | 1.18 |
| 23andMe Holding Co. (ME)vs › | $15.31M | -9.05 | -19.23 | -15.56 | -14.25 |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.06B | -0.09 | 0.57 | 0.18 | -0.06 |
| Oscar Health, Inc. (OSCR)vs › | $7.81B | -0.54 | -0.79 | -1.41 | -1.76 |
| Tempus AI, Inc. (TEM)vs › | $8.18B | -1.44 | -3.00 | -2.43 | -2.16 |
| Insulet Corp. (PODD)vs › | $9.23B | 5.35 | 4.74 | 3.13 | 2.14 |
Trailing EPS (TTM)
$3.86
Forward EPS (Est.)
$1.83
P/E Ratio
19.8
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 5.60 |
| 2024-12-31 | 1.07 |
| 2023-12-31 | -0.77 |
| 2022-12-31 | -1.23 |
| 2021-12-31 | -1.60 |
| 2020-12-31 | -1.16 |
| 2019-12-31 | -2.36 |
| 2018-12-31 | -1.23 |
| 2017-12-31 | -1.44 |
| 2016-12-31 | -1.66 |
